" class="no-js "lang="en-US"> Eric Slosberg - Medtech Alert
Friday, March 27, 2026
Eric Slosberg

Eric Slosberg

About Eric Slosberg

Highly credentialed cross-functional hematology/oncology drug development leader offering over twenty years experience in directing and conducting drug research and development in large and mid-sized pharma companies. Proven track record of successful line management and matrix leadership of complex multinational, cross-functional teams. Experienced in creating new roles and building teams in dynamic, resource-constrained environments. Expertise in strategic portfolio development, design of clinical development plans and hands-on execution of clinical trials. Deep experience in data analysis and interpretation, preclinical, biomarker and translational research, life-cycle management, external communications and medical affairs.

Related Story

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

June 30 2021

OnCusp Therapeutics (or “OnCusp”), a global biopharmaceutical company focused on translating cutting-edge research assets into […]